Dazodalibep
Horizon Therapeutics
['dazodalibep']
#eular2023 #lb0003 it is unheard of therapies that potentially can improve sjogren patients with high symptoms burden. phase 2 rct of dazodalibep (cd40l-i) showed esspri improved vs pbo. numerical improvement in other secondary (fatigue). will await results in phase 3 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏